$ASTSBearishMed

Blue Origin Explosion Prompts Analyst To Push AST SpaceMobile (NASDAQ: ASTS) Coverage Timeline To 2028

AST SpaceMobile (ASTS) shares fell about 5% premarket after a Blue Origin New Glenn explosion during a hotfire test at Cape Canaveral, with Blue Origin saying all personnel were safe and an investigation is underway. Analyst Tim Farrar warned continuous service may not arrive before 2028 and that 2027 revenue could be limited. Deutsche Bank downgraded ASTS to Hold; Roth kept Buy but flagged deployment timing risk.

9/10
5/10
Med
Bearish
Premarket today after Blue Origin’s New Glenn explosion and analyst coverage timeline push.
Risk-off for space/launch-dependent names; ASTS specifically repriced toward slower path to continuous service.

Higher probability of slipping 2026 deployment targets and pushing meaningful commercial revenue beyond 2027 due to launch interruptions.

AST SpaceMobile faces delayed deployment risk as Blue Origin’s New Glenn explosion threatens launch cadence and continuous service timing to 2028.

Bearish near-term as investors reprice deployment pace; downside risk persists until launch schedule clarity emerges.

Background

Blue Origin’s New Glenn hotfire explosion occurred ahead of an anticipated fourth mission; ASTS previously had a May setback where an upper-stage anomaly prevented BlueBird 7 from reaching orbit.

Why it matters

The incident adds another New Glenn delay risk, reinforcing concerns that ASTS’s path to continuous commercial coverage may extend to 2028 and that 2027 revenue could be limited if service is intermittent.

Market relevance

ASTS is the core tradable name: launch cadence risk is reframed toward a later continuous-service timeline, aligning with a downgrade and caution from analysts.

Market effects

Launch-reliability shock increases perceived timeline risk for satellite deployment and commercial service monetization across space infrastructure.

Primarily impacts US-listed space stocks in premarket; no direct non-US operational detail provided.

Could affect global satellite-communications deployment expectations if New Glenn delays propagate into broader launch availability assumptions.

Alternative perspectives

ASTS may still meet satellite deployment counts via alternative Falcon 9 opportunities; intermittent coverage could still build traction even if continuous service slips.

The article relies on analyst inference (continuous service timing) rather than confirmed contract changes; actual launch manifests and payload integration outcomes could differ from the cautious framing.

Key entities

  • AST SpaceMobile

    Subject of the article; deployment pace and continuous service timeline are questioned after New Glenn’s explosion and a prior BlueBird 7 orbit failure.

  • Blue Origin

    New Glenn rocket failure during hotfire test; investigation underway and mission timing uncertainty increases.

  • Deutsche Bank

    Downgraded ASTS to Hold citing launch delays versus 2026 deployment targets.

  • Roth Capital

    Maintained Buy on ASTS but warned the incident could push commercial deployment from late 2026 into early 2027.

Related articles

$LUNRMedAI 8/10

Intuitive Machines (LUNR) Stock Is Sinking. The SpaceX IPO Is Only Partly to Blame.

Intuitive Machines shares fell on Wednesday, with the article saying the SpaceX IPO is only partly responsible. It notes a share-issuance program run by a consortium of 10 financial institutions (including Barclays, Cantor Fitzgerald, and Deutsche Bank) that can collect up to 3% commissions and allows continuous issuance at market prices, creating dilution risk. Analysts maintain a “Moderate Buy” consensus and a mean ~$41 price target (~20% upside).

$RKLBLow

Should You Buy RocketLab Stock Instead of SpaceX at IPO?

The article discusses rising investor interest in space-related stocks, highlighting Rocket Lab (RKLB) shares up 4.61% as of June 2, 2026 afternoon prices. It frames the question of whether Rocket Lab stock should be considered instead of SpaceX around its IPO, but provides no additional financial figures or company-specific details.

$RKLBMed

Space nerds, rejoice! SpaceX’s IPO lifts dreams of the cosmos.

SpaceX’s upcoming IPO has drawn major attention from space enthusiasts and investors. The company set an IPO price of $135 per share, valuing it at about $1.77 trillion, according to the report. RocketLab and Intuitive Machines shares have risen as the deal nears, and analysts said a successful IPO could boost broader space-industry investment.

$RKLBMed

Jamie Dimon Pitches SpaceX IPO To 2,500 Wealthy Clients As Space Stocks (NASDAQ: RKLB), (NASDAQ: LUNR), (NASDAQ: FLY), (NASDAQ: SIDU) Recover

Space stocks rebounded after a Wednesday selloff tied to concerns about SpaceX’s valuation ahead of its June 12 Nasdaq debut. Bloomberg reported JPMorgan CEO Jamie Dimon will pitch the SpaceX IPO to 2,500 wealthy clients with SpaceX executives. SpaceX set a $135/share price, targeting a $75B raise and >$1.8T valuation; up to 30% may go to individuals. Rocket Lab, Intuitive Machines, and Sidus rose ~1%; Firefly gained 0.5%.